These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6541692)

  • 1. Hydrolytic deactivation of kyotorphin by the rodent brain homogenates and sera.
    Matsubayashi K; Kojima C; Kawajiri S; Ono K; Takegoshi T; Ueda H; Takagi H
    J Pharmacobiodyn; 1984 Jul; 7(7):479-84. PubMed ID: 6541692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of kyotorphin by a purified membrane-bound-aminopeptidase from monkey brain: potentiation of kyotorphin-induced analgesia by a highly effective inhibitor, bestatin.
    Ueda H; Ming G; Hazato T; Katayama T; Takagi H
    Life Sci; 1985 May; 36(19):1865-71. PubMed ID: 3990513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How is kyotorphin (Tyr-Arg) generated in the brain?
    Ueda H; Yoshihara Y; Nakamura A; Shiomi H; Satoh M; Takagi H
    Neuropeptides; 1985 Feb; 5(4-6):525-8. PubMed ID: 4000421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidase activities in rat brain synaptosomes can be distinguished on the basis of inhibition by bestatin and amastatin: identification of a kyotorphin (Tyr-Arg)-degrading enzyme.
    Orawski AT; Simmons WH
    Neurochem Res; 1992 Aug; 17(8):817-20. PubMed ID: 1641064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An enkephalin-degrading aminopeptidase from rat brain catalyzes the hydrolysis of a neuropeptide, kyotorphin (L-Tyr-L-Arg).
    Akasaki K; Tsuji H
    Chem Pharm Bull (Tokyo); 1991 Jul; 39(7):1883-5. PubMed ID: 1777940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kyotorphin (L-tyrosyl-L-arginine) as a possible substrate for inducible nitric oxide synthase in rat glial cells.
    Arima T; Kitamura Y; Nishiya T; Takagi H; Nomura Y
    Neurosci Lett; 1996 Jul; 212(1):1-4. PubMed ID: 8823748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sites of analgesic actions of kyotorphin and D-kyotorphin in the central nervous system of rats.
    Satoh M; Wada T; Iwama T; Takagi H
    Neuropeptides; 1985 Feb; 5(4-6):415-8. PubMed ID: 4000414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of two distinct kyotorphin-hydrolyzing enzymes in rat brain.
    Akasaki K; Nakamura A; Shiomi H; Tsuji H
    Neuropeptides; 1991 Oct; 20(2):103-7. PubMed ID: 1798437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of kyotorphin (L-tyrosyl-L-arginine) ON[3H]NG-nitro-L-arginine binding to neuronal nitric oxide synthase in rat brain.
    Arima T; Kitamura Y; Nishiya T; Taniguchi T; Takagi H; Nomura Y
    Neurochem Int; 1997 Jun; 30(6):605-11. PubMed ID: 9153002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of the analgesic neuropeptides kyotorphin and neo-kyotorphin on enkephalin-degrading enzymes from monkey brain.
    Hazato T; Kase R; Ueda H; Takagi H; Katayama T
    Biochem Int; 1986 Mar; 12(3):379-83. PubMed ID: 3011001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor.
    Chaillet P; Marçais-Collado H; Costentin J; Yi CC; De La Baume S; Schwartz JC
    Eur J Pharmacol; 1983 Jan; 86(3-4):329-36. PubMed ID: 6572590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central antinociceptive effect of L-ornithine, a metabolite of L-arginine, in rats and mice.
    Kawabata A; Iwatsubo K; Takaya S; Takagi H
    Eur J Pharmacol; 1996 Jan; 296(1):23-31. PubMed ID: 8720473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake and release of kyotorphin in rat brain synaptosomes.
    Ueda H; Matsumoto S; Yoshihara Y; Fukushima N; Takagi H
    Life Sci; 1986 Jun; 38(26):2405-11. PubMed ID: 3724363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kyotorphin (tyrosine-arginine) synthetase in rat brain synaptosomes.
    Ueda H; Yoshihara Y; Fukushima N; Shiomi H; Nakamura A; Takagi H
    J Biol Chem; 1987 Jun; 262(17):8165-73. PubMed ID: 3597366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral non-opioid analgesic effects of kyotorphin in mice.
    Inoue M; Nakayamada H; Tokuyama S; Ueda H
    Neurosci Lett; 1997 Oct; 236(1):60-2. PubMed ID: 9404952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic dipeptide, kyotorphin (Tyr-Arg), is highly concentrated in the synaptosomal fraction of the rat brain.
    Ueda H; Tatsumi K; Shiomi H; Takagi H
    Brain Res; 1982 Jan; 231(1):222-4. PubMed ID: 6275947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of central injection of kyotorphin and L-arginine on oxytocin and vasopressin release and blood pressure in conscious rats.
    Summy-Long JY; Bui V; Gestl S; Koehler-Stec E; Liu H; Terrell ML; Kadekaro M
    Brain Res Bull; 1998; 45(4):395-403. PubMed ID: 9527014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hydrolytic activities of human dipeptidases toward leukotriene D4 and kyotorphin by captopril.
    Ito Y; Iwaki M; Ogiso T; Nakamura S; Kato K; Sawaki S
    Clin Exp Hypertens A; 1987; 9(2-3):681-5. PubMed ID: 3301087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-activated neutral protease (CANP), a putative processing enzyme of the neuropeptide, kyotorphin, in the brain.
    Yoshihara Y; Ueda H; Imajoh S; Takagi H; Satoh M
    Biochem Biophys Res Commun; 1988 Sep; 155(2):546-53. PubMed ID: 2844173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal transport and metabolism of analgesic dipeptide, kyotorphin: rate-limiting factor in intestinal absorption of peptide as drug.
    Mizuma T; Koyanagi A; Awazu S
    Biochim Biophys Acta; 1997 Apr; 1335(1-2):111-9. PubMed ID: 9133647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.